Anti-small molecules

Anti-small molecule antibodies are tailored to specifically recognize haptens, including organic small molecules and short peptide chains with unique conformations. AtaGenix provides comprehensive customization services, covering small molecule synthesis and conjugation, animal immunization, antibody screening and purification, as well as recombinant expression and functional validation.

To meet diverse research needs, AtaGenix employs advanced platforms such as the Single B Rabbit Monoclonal Antibody Screening Platform, Mouse Hybridoma Monoclonal Antibody Screening Platform, Rat/Rabbit Polyclonal Antibody Screening Platform, and the Phage Display Antibody Library Platform, ensuring high-quality, precise solutions.

Tailored Solutions

Custom small molecule antibody services
Advanced Platforms

Cutting-edge screening technologies
Reliable Results

Specific and high-quality antibodies

Anti-small molecules Technology Roadmap

The development of small molecule antibodies begins by conjugating non-immunogenic small molecules with immunogenic protein carriers to create antigenic conjugates. This process enables immune recognition, laying the foundation for high-quality antibody production.

Through immunization, mice produce monoclonal antibodies with high specificity, while rabbits generate polyclonal antibodies with broad epitope coverage. This streamlined approach ensures versatile antibody solutions for research, diagnostics, and therapeutic applications.

By Method

By Application

Anti-small molecules

Anti-small molecules Technology Roadmap

More Featured Antibody Services

Featured Services

Ask us

About us

Core Technologies

Resource Center